SMARTevans: Quantifying Skin Oxygenation Properties in Normal vs Sun Exposed Skin

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT03311191
Collaborator
Procter and Gamble (Industry)
11
1
22.6
0.5

Study Details

Study Description

Brief Summary

This research study aims to determine if there are differences in oxygen consumption between chronically sun exposed and less sun exposed skin. This study uses a new imaging device that can detection oxygenation properties skin in a non-invasive manner.

Condition or Disease Intervention/Treatment Phase
  • Device: Measurement of skin oxygenation and oxygen consumption

Detailed Description

Sun and ultraviolet light exposure has both short term and long term effects on skin. While the short term effects, such as sunburn, are understood, chronic long-term sun exposure can cause changes to the skin that are not well characterized. One particular alteration may be how the skin consumes oxygen, a change that may be linked to biochemical alterations that have been observed in past studies. Measuring skin oxygen consumption has traditionally been difficult as the tools available have not been easy to incorporate into clinical studies. In this study, we overcome this barrier through the use of a new non-invasive oxygen-sensing device that can rapidly measure skin oxygenation properties such as oxygen consumption. This observational study will measure the oxygenation properties of both chronically sun exposed and less sun exposed skin in the predefined groups of both young and older men and women.

Study Design

Study Type:
Observational
Actual Enrollment :
11 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Quantifying Skin Oxygenation Properties in Normal vs Sun Exposed Skin
Actual Study Start Date :
Jul 17, 2017
Actual Primary Completion Date :
Jun 6, 2019
Actual Study Completion Date :
Jun 6, 2019

Arms and Interventions

Arm Intervention/Treatment
Younger Women

Women ages 20-30 who are not pregnant will be painted with oxygen sensing bandage

Device: Measurement of skin oxygenation and oxygen consumption
Oxygenation properties will be measured using a transparent paint-on bandage formulation that consists of New-Skin liquid bandage, an oxygen-sensing metallo-porphyrin exhibiting bright red phosphorescence, and the green-fluorescing reference dye fluorescein.

Younger Men

Men ages 20-30 will be painted with oxygen sensing bandage

Device: Measurement of skin oxygenation and oxygen consumption
Oxygenation properties will be measured using a transparent paint-on bandage formulation that consists of New-Skin liquid bandage, an oxygen-sensing metallo-porphyrin exhibiting bright red phosphorescence, and the green-fluorescing reference dye fluorescein.

Older Women

Women ages 55-65 who are not pregnant will be painted with oxygen sensing bandage

Device: Measurement of skin oxygenation and oxygen consumption
Oxygenation properties will be measured using a transparent paint-on bandage formulation that consists of New-Skin liquid bandage, an oxygen-sensing metallo-porphyrin exhibiting bright red phosphorescence, and the green-fluorescing reference dye fluorescein.

Older Men

Men ages 55-65 will be painted with oxygen sensing bandage

Device: Measurement of skin oxygenation and oxygen consumption
Oxygenation properties will be measured using a transparent paint-on bandage formulation that consists of New-Skin liquid bandage, an oxygen-sensing metallo-porphyrin exhibiting bright red phosphorescence, and the green-fluorescing reference dye fluorescein.

Outcome Measures

Primary Outcome Measures

  1. Differences in the relative (sun exposed vs nonexposed) and absolute oxygen properties within an individual and between the two age groups [20 min estimated per subject]

    The skin's partial pressure of oxygen and oxygen consumption rate is measured at 4 different locations on the subjects arms using the oxygen sensing device, where it is expected that that difference between more sun exposed regions and less sun exposed regions will be greater in the population of older adults.

Secondary Outcome Measures

  1. The differences in the relative (sun exposed vs nonexposed) and absolute oxygen properties between the sexes [20 min estimated per subject]

    The skin's partial pressure of oxygen and oxygen consumption rate is measured using the oxygen sensing device and compared between the sexes (arm 1+3 and arm 2+4)

Other Outcome Measures

  1. The oxygen properties connected to lifestyle choices, such as sun-seeking behavior, lifetime sun exposure levels, and smoking. [20 min estimated per subject, plus time to fill in questionnaire response]

    The skin's partial pressure of oxygen and oxygen consumption rate is measured with the oxygen sensing device and compared between groups stratified by lifestyle, as based on subject responses from the questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female

  • Age groups: 20 - 30 and 55 - 65

  • Fitzpatrick skin types I, II, III, and IV

Exclusion Criteria:
  • Fitzpatrick skin types V and above

  • Tattoo markings anywhere on the arm(s)

  • Significant scarring or discoloration (e.g. birthmarks) on the arm(s)

  • Any current injuries, infections or wounds on the arm(s)

  • Routinely (4+ doses per week) take high dosages of anti-inflammatory drugs (e.g. aspirin, ibuprofen, corticosteroids), immunosuppressive drugs, or antihistamine medications. However steroid nose drops and/or eye drops are permitted.

  • Has taken an anti-inflammatory drug (e.g. aspirin) within the prior 24 hours of the study visit.

  • Have diabetes that is treated with injectable or oral insulin

  • Have any other active or chronic skin problems on the arms

  • Are currently participating in another skin care product study at this or any other facility

  • Have participated in any type of skin product treatment study within the past 2 weeks

  • Have or ever have had dermatographia

  • Pregnant women

  • Lactating women

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital
  • Procter and Gamble

Investigators

  • Principal Investigator: Conor L Evans, PhD, Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Conor L Evans, Assistant Professor, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT03311191
Other Study ID Numbers:
  • 2017P000695
First Posted:
Oct 17, 2017
Last Update Posted:
Aug 14, 2019
Last Verified:
Aug 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 14, 2019